Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Colorectal Neoplasms

Free Subscription 01.12.2025 1 Adv Exp Med Biol 6 BMC Cancer 4 BMC Gastroenterol 1 Br J Cancer 1 Cancer 2 Cancer Lett 1 Dis Colon Rectum 2 Eur J Cancer 5 Eur J Surg Oncol 1 Gastrointest Endosc 1 Gut 1 Int J Cancer 5 J Surg Oncol 2 Lancet Oncol 2 N Engl J Med 1 Oncogene 1 PLoS Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Adv Exp Med Biol

1. MAKRYGIANNI P, Polikandrioti M, Koutelekos I, Tsiampouris I, et al
   Anxiety and Depression in Patients with Colorectal Cancer Undergoing Ileostomy: A Systematic Review.
   Adv Exp Med Biol. 2026;1487:493-501.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. YANG Q, Hu Y, Liu F
   Secular trend of colorectal cancer related with low physical activity from 1990 to 2021 in China.
   BMC Cancer. 2025 Nov 26. doi: 10.1186/s12885-025-15290.
   PubMed         Abstract available
   
   
3. XIE HB, Zhang BB, Zhao L, Liu L, et al
   Prealbumin predicts metachronous liver metastasis in colorectal cancer.
   BMC Cancer. 2025 Nov 25. doi: 10.1186/s12885-025-15296.
   PubMed         Abstract available
   
   
4. WANG L, Wu H, Chen Y, Wang G, et al
   Single-cell RNA sequencing reveals neutrophil differentiation-related genes for immunotherapy response prediction in colorectal cancer.
   BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15355.
   PubMed        
   
   
5. LI K, Zhang R, Zhang J, Zhang Z, et al
   The prognostic role of inflammation-based hematologic markers in stage I-III colorectal cancer: a retrospective analysis.
   BMC Cancer. 2025;25:1822.
   PubMed         Abstract available
   
   
6. JIN X, Bai B, Pan Y, Xie S, et al
   Distinct clinical features and epidemiological trends of very early and middle-aged early onset colorectal cancer based on SEER 17 and GBD 2021 data over the past 15 years.
   BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15263.
   PubMed         Abstract available
   
   
7. PASSARDI A, Sullo FG, Bittoni A, Matteucci L, et al
   CombiCoR-Vax trial: study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cance
   BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15371.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

8. YU H, He Y, Lv T, Lu X, et al
   Prognostic value of the platelet-to-lymphocyte ratio in colorectal cancer patients undergoing chemotherapy: a systematic review and meta-analysis.
   BMC Gastroenterol. 2025;25:834.
   PubMed         Abstract available
   
   
9. CHENG S, Chen L, Liu S, Zhang H, et al
   Association of lifestyle and dietary preferences with precancerous serrated polyps: a hospital-based case-control study in Guangzhou, China.
   BMC Gastroenterol. 2025;25:837.
   PubMed         Abstract available
   
   
10. BOUBACAR E, Balaraba ABA, Idrissa B, Mahamadou AA, et al
    Colorectal cancer in young: a 5-year study from a sub-Saharan African country.
    BMC Gastroenterol. 2025;25:844.
    PubMed         Abstract available
    
    
11. CHEN S, Wen M, Lv F, Yan L, et al
    Diagnostic value of Gd-EOB-DTPA-enhanced MRI versus contrast-enhanced CT for detecting liver metastasis in colorectal cancer: a systematic review and meta-analysis.
    BMC Gastroenterol. 2025 Nov 27. doi: 10.1186/s12876-025-04509.
    PubMed         Abstract available
    
    

    
    Br J Cancer

12. LEE HJ, Lee JH, Kang J, Kim K, et al
    Single-cell multiomic modelling of early metastatic events promoted by the extracellular matrix.
    Br J Cancer. 2025;133:1708-1719.
    PubMed         Abstract available
    
    

    
    Cancer

13. MYERS S, Davis ES, Franks JA, Davids JS, et al
    Beyond composite measures of regional vulnerability: Rural-urban colorectal cancer mortality disparities mediated by area-level characteristics.
    Cancer. 2025;131:e70098.
    PubMed         Abstract available
    
    

    
    Cancer Lett

14. ERMINE K, Chen D, Hao S, Liu Z, et al
    Reactivating necroptosis in colorectal cancer potentiates chemotherapy and antitumor immune responses.
    Cancer Lett. 2025 Nov 26:218169. doi: 10.1016/j.canlet.2025.218169.
    PubMed         Abstract available
    
    
15. TANG W, Lv Y, Xie H, Wei Y, et al
    Efficacy and safety of SHR-1701 combined with chemoradiotherapy as neoadjuvant treatment for locally advanced rectal cancer.
    Cancer Lett. 2026;636:218006.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

16. ISHIZAKI T, Nagakawa Y, Yokozuka K, Kobayashi T, et al
    Robotic Management of Recurrent Peritoneal Colon Cancer.
    Dis Colon Rectum. 2025 Nov 25. doi: 10.1097/DCR.0000000000004025.
    PubMed        
    
    

    
    Eur J Cancer

17. WERF-'T LAM AV, Dowty JG, Italia M, Bakker AC, et al
    Cancer risks for MSH6 pathogenic variant carriers.
    Eur J Cancer. 2025;231:116098.
    PubMed         Abstract available
    
    
18. VANDE KERCKHOVE FEC, van den Berg K, van Erning FN, Daniels-Gooszen AW, et al
    Implications of inaccurate lymph node staging in early and intermediate-risk rectal cancer on survival-related outcomes in a large Dutch population-based cohort.
    Eur J Cancer. 2025;231:116052.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

19. DE GRAAFF MR, Kok NFM, Grunhagen DJ, Nielen M, et al
    Influence of socioeconomic position on surgical outcomes after resection of colorectal liver metastases.
    Eur J Surg Oncol. 2025;51:110459.
    PubMed         Abstract available
    
    
20. STICCA G, Soucisse M, Abou-Khalil M, Gervais MK, et al
    Safety of high-dose mitomycin C vs oxaliplatin HIPEC for peritoneal metastases.
    Eur J Surg Oncol. 2025;51:110534.
    PubMed         Abstract available
    
    
21. ALTINSOY E, Ozcan VC, Zeynalov H, Cebeci? E, et al
    An onco-vascular surgical approach: Internal iliac artery transposition for external iliac artery repair during cytoreductive surgery.
    Eur J Surg Oncol. 2025;51:110503.
    PubMed         Abstract available
    
    
22. VAN DEN HEUVEL TBM, van Erning FN, Hemmer PHJ, Madsen EVE, et al
    Recurrence patterns following CRS-HIPEC in patients with colorectal peritoneal metastases: Insights from the Dutch CRS-HIPEC registry.
    Eur J Surg Oncol. 2025;51:110501.
    PubMed         Abstract available
    
    
23. CHATZIPANAGIOTOU OP, Kawashima J, Baldo A, Ruzzenente A, et al
    Time-varying hazards of recurrence patterns among patients with colorectal liver metastases undergoing liver resection and the role of the modified tumor burden score.
    Eur J Surg Oncol. 2025;51:110527.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

24. SOOD A, Herman N, Hung CK
    Safety of Endoscopy Following Recent Bevacizumab Use in Metastatic Colorectal Cancer.
    Gastrointest Endosc. 2025 Nov 20:S0016-5107(25)02201.
    PubMed         Abstract available
    
    

    
    Gut

25. GRANCHER A, Denis B, Plaine J, Vidal-Sengchanh S, et al
    Does a long time to colonoscopy after a positive faecal immunochemical test result have a deleterious impact on colorectal cancer outcomes? A nationwide cohort study.
    Gut. 2025 Nov 27:gutjnl-2025-336036. doi: 10.1136/gutjnl-2025-336036.
    PubMed         Abstract available
    
    

    
    Int J Cancer

26. HJORTH CF, Olsen MH, Ulrichsen SP, Nors J, et al
    Body mass index and colorectal cancer recurrence and mortality: A nationwide cohort study in Denmark.
    Int J Cancer. 2025 Nov 21. doi: 10.1002/ijc.70248.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

27. GOULD LE, Pring ET, Drami I, Constantinides J, et al
    Gluteal Flap Reconstruction Following Complex Rectal Cancer Surgery: A Large Consecutive Series of Perineal Wounds Exploring Risk Factors for Complications.
    J Surg Oncol. 2025;132:1399-1406.
    PubMed         Abstract available
    
    
28. AL DHAHERI M, Mubarak R, Toffaha A, AbuNada M, et al
    Organ Preserving or Radical Surgery? A Systematic Review and Meta-Analysis of Transanal Local Excision Versus Total Mesorectal Excision After Neoadjuvant Therapy for Rectal Cancer.
    J Surg Oncol. 2025;132:1337-1355.
    PubMed         Abstract available
    
    
29. CENGIZ F, Gunay S, Vatansever S, Kiziltoprak N, et al
    Functional Outcomes After Rectal ESD: A Retrospective Evaluation of Low Anterior Resection Syndrome.
    J Surg Oncol. 2025;132:1331-1336.
    PubMed         Abstract available
    
    
30. EMILE SH, Horesh N, Garoufalia Z, Oosenbrug M, et al
    A Seer-Based Analysis of Survival Predictors in Stage I Colorectal Adenocarcinomas.
    J Surg Oncol. 2025;132:1320-1330.
    PubMed         Abstract available
    
    
31. LE V, Franko J, Fong Y
    Complete Cytoreduction of Colorectal Liver Metastases: Evolving Systemic Therapy and Liver Transplantation.
    J Surg Oncol. 2025;132:1317-1319.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

32. AMATU A, Patelli G, Zampino MG, Bergamo F, et al
    Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.
    Lancet Oncol. 2025;26:1612-1625.
    PubMed         Abstract available
    
    
33. KIM S, Boustani J, Iseas S, Vernerey D, et al
    Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial.
    Lancet Oncol. 2025;26:1626-1637.
    PubMed         Abstract available
    
    

    
    N Engl J Med

34. GUO Q, Zhao Y, Yin C
    Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer.
    N Engl J Med. 2025;393:2173.
    PubMed        
    
    
35. MARTLING A, Myrberg IH, Lindberg J
    Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer. Reply.
    N Engl J Med. 2025;393:2173.
    PubMed        
    
    

    
    Oncogene

36. LV M, Hu C, Li J, Zhang Y, et al
    Serotonin receptor type 7 (5-HT7) promotes colorectal cancer progression by activating Wnt/beta-catenin signaling via interacting with CK1epsilon.
    Oncogene. 2025 Nov 26. doi: 10.1038/s41388-025-03645.
    PubMed         Abstract available
    
    

    
    PLoS Med

37. XIE J, Dong X, Luo Z, Wang C, et al
    The impact of adherence on colorectal cancer screening cost-effectiveness: A modeling study.
    PLoS Med. 2025;22:e1004807.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.